Evidence map›Paper›PMID 34751412›Full record

ArticleMolecular medicine reports2022

Repigmentation by combined narrow‑band ultraviolet B/adipose‑derived stem cell transplantation in the mouse model: Role of Nrf2/HO‑1‑mediated Ca

Yuanyuan Bian, Hao Yu, Mingzhu Jin, Xinghua Gao

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Food science & nutrition · 2024
    Article
  10. Article
  11. Endoplasmic Reticulum Dysfunction: An Emerging Mechanism of Vitiligo Pathogenesis.Clinical, cosmetic and investigational dermatology · 2024
    Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yuanyuan Bian *Department of Dermatovenereal Disease, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Hao Yu *Department of Endocrinology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, P.R. China.
Mingzhu JinDepartment of Dermatovenereal Disease, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Xinghua GaoDepartment of Dermatovenereal Disease, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
China Medical University · CNGeneral Hospital of Shenyang Military Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitiligo is a depigmentation disease commonly seen in clinical practice, mainly involving loss of functional epidermal pigment cells and hair follicle melanocytes. Narrow‑band ultraviolet B (NB‑UVB) has emerged as the first choice of treatment for vitiligo, but long‑term exposure may have serious consequences. Recently, it was reported that adipose‑derived stem cells (ADSCs) improve melanocyte growth and the efficacy of melanocyte transplantation. The present study aimed to examine the efficacy of NB‑UVB/ADSC‑transplantation combined therapy on a mouse vitiligo model and explore the underlying mechanisms by focusing on endoplasmic reticulum stress and cellular calcium (Ca

Indexed as

AnimalsCalciumChinaEndoplasmic Reticulum StressEpidermisFemaleHair FollicleHomeostasisHydroquinonesMelanocytesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMiceMice, Inbred C57BLNF-E2-Related Factor 2Oxidative StressCalciumHydroquinonesmonobenzoneNfe2l2 protein, mouseNF-E2-Related Factor 2adipose‑derived stem cellscalcium homeostasisendoplasmic reticulum stressnarrow‑band ultraviolet Bnuclear factor erythroid 2 like 2 signalingvitiligo

Identifiers

PMID34751412
PMCPMC8600419
OpenAlexW3214544583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.